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Abstract The role of retinoic acids (RA) on liver fatty acid-
binding protein (L-FABP) expression was investigated in the well 
differentiated FAO rat hepatoma cell line. 9-cis-Retinoic acid 
(9-ci's-RA) specifically enhanced L-FABP mRNA levels in a 
time- and dose-dependent manner. The higher induction was 
found 6 h after addition of 1 0 - 6 M 9 - C K - R A in the medium. RA 
also enhanced further both L-FABP mRNA levels and cytosolic 
L-FABP protein content induced by oleic acid. The retinoid X 
receptor (RXR) and the peroxisome proliferator-activated 
receptor (PPAR), which are known to be activated, respectively, 
by 9-c/s-RA and long chain fatty acid (LCFA), co-operated to 
bind specifically the peroxisome proliferator-responsive element 
(PPRE) found upstream of the L-FABP gene. Our result suggest 
that the PPAR-RXR complex is the molecular target by which 
9-cis-RA and LCFA regulate the L-FABP gene. 
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1. Introduction 
Liver fatty acid-binding protein (L-FABP) is a small cyto-
solic protein which binds long chain fatty acids (LCFA) with 
a high affinity. Although the precise function of this abundant 
protein is not yet known, it is thought to play an important 
role in the intracellular fatty acid (FA) trafficking and metab-
olism (reviewed in [1]). Recently, we have reported that LCFA 
can directly trigger the transcriptional induction of the 
L-FABP gene in rat F A O hepatoma cells [2]. Similar results 
have also been reported for other proteins involved in lipid 
metabolism (reviewed in [3]). Several lines of evidence suggest 
that this up-regulation is likely mediated through the interac-
tion of specific nuclear receptors termed peroxisome prolif-
erator-activated receptors (PPARs) with a specific response 
element (PPRE) located in the promoter of target genes [4-
6]. The investigation of key genes involved in the peroxisomal 
fj-oxidation, i.e. acyl-CoA oxidase (ACO) and bifunctional 
enzyme (BFE), has shown that retinoid X receptors (RXRs) 
are required for PPARs to bind to the P P R E [7-9]. Since 
*Corresponding author. Fax: (33) (3) 80 39 66 91. 
E-mail: pbesnard@u-bourgogne.fr 
Abbreviations: L-FABP, liver fatty acid-binding protein; ACO, acyl-
CoA oxidase; BFE, bifunctional enzyme; RA, retinoic acids; 9-cis-
RA, 9-c«-retinoic acid; FA, fatty acid; LCFA, long chain fatty acid; 
PPAR, peroxisome proliferator-activated receptor; FAAR, fatty acid-
activated receptor; RXR, retinoid X receptor; PPRE, peroxisome 
proliferator-responsive element 
9-cw-retinoic acid (9-cis-RA) specifically activates the R X R s 
[10,11] and a PPRE-like sequence exists in the L-FABP pro-
moter [12], we have explored the effect of this retinoid on 
L-FABP expression in the F A O cells. The data reported 
here provide evidence that 9-cis-RA is involved in the regu-
lation of the L-FABP gene and enhances the up-regulation 
triggered by LCFAs most likely through a P P A R - R X R com-
plex. 
2. Materials and methods 
2.1. Cell cultures and treatments 
FAO cells are a well-differentiated subclone derived from the rat 
hepatoma H4 II EC3 line. They were cultured at 37°C in a humidified 
atmosphere of 5% CO2, 95% air in Ham F-12 medium (Gibco-BRL) 
containing 10% fetal calf serum, penicillin (200 IU/ml) and strepto-
mycin (50 mg/ml) according to previously published procedures [2]. 
The culture medium was changed every 48 h. Experiments were per-
formed on subconfluent cells maintained in culture under serum-free 
conditions. All trans-RA and 9-cis-RA (gift from Hoffman-La Roche) 
were dissolved in dimethyl sulfoxide (DMSO) while oleic acid was 
complexed to FA-free bovine serum albumine (BSA). 
2.2. Molecular probes 
The L-FABP cDNA probe was generously provided by Dr J.I. 
Gordon (Washington University, St. Louis, MO, USA). Mouse 
PPARa, PPARp/FAAR and PPARyl were generously provided by 
S. Green (Imperial Chemical Industries, Cheshire, UK), P. Grimaldi 
(Universite de Nice, France) and R. Evans (Howard Hughes Medical 
Institute, La Jolla, CA 92037), respectively. Mouse RXR(3 was a kind 
gift of K. Ozato (National Institute of Health, Bethesda, MA 20892) 
and mouse [3-actin cDNA was a gift from A. Alonso (Institut Pasteur, 
Paris, France). These probes were labeled with [a32P]dCTP (3000 Ci/ 
mmol; Amersham) by random priming (Megaprime kit, Amersham). 
A 24-residue oligonucleotide specific for rat 18S rRNA was used to 
test the loading of equivalent amounts of RNAs and their efficient 
transfer. This oligonucleotide was 5' end-labeled using T4 polynucleo-
tide kinase and [y^PJATP (3000 Ci/mmol, Amersham). 
2.3. Northern blot analysis 
Total RNA was extracted from according to Chomczynski and 
Sacchi [13]. Thirty ug of Total RNA were denatured, electrophoresed 
on a 1% agarose gel and transferred to Gene Screen membrane 
(NEN) using 20-fold concentrated 150 mM NaCl and 15 mM triso-
dium citrate, pH 7 (NaCl/Cit). Filters were prehybridized for 4 h then 
hybridized for 16 h at 42°C according to previously published proce-
dures [14]. For L-FABP, PPARp/FAAR and p-Actin probes, filters 
were washed successively two times in 2XNaCl/Cit at room temper-
ature for 5 min, in 2 X NaCl/Cit with 1% SDS at 55°C for 30 min and 
in 0.1 XNaCl/Cit at room temperature for 30 min. For PPARa and 
PPARyi probes, they were washed three times with 2XNaCl/Cit at 
37°C for 15 min. Autoradiograms were quantified with an automatic 
densitometric scanner (CS-9000, Shimadzu, Scientific Instruments). 
2.4. Western blot analysis 
Cellular homogenates were prepared in ice-cold 50 mM Tris-HCl, 
5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF) in a 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 8 3 0 - 2 
H. Poirier et al.lFEBS Letters 412 (1997) 480-484 481 
glass teflon potter. The homogenates were centrifuged for 10 min at 
18000 g. The resulting supernatants were centrifuged for 60 min at 
105 000 g before to be stored at —20°C until analysis. The rabbit anti-
rat L-FABP antiserum and the purified rat L-FABP were generously 
provided by Dr. J.I. Gordon (St Louis, MO, USA). The cytosolic 
protein concentration was measured by BCA (Pierce) and 10 ug de-
natured proteins were separated by Sodium Dodecyl Sulfate Polya-
crylamide Gel Electrophoresis (SDS-PAGE) as described elsewhere 
[14]. After transfer on filter, the antigen-antibody complexes were 
detected by chemiluminescence (ECL-system; Amersham). 
2.5. Production of nuclear proteins and gel shift analysis 
Nuclear receptors (i.e. mPPARa, mPPARpVFAAR, mPPARyl and 
mRXR|3) were produced from the pSG5 expression plasmid using the 
TNT rabbit reticulocytes translation system as directed by the supplier 
(Promega). A sense strand oligonucleotide containing the PPRE se-
quence (underlined) of the L-FABP gene (S'-AAGCTTCAATCACT; 
GACCTATGGCCTATATTTGTCTAGA-3') was annealed with the 
corresponding antisense strand oligonucleotide, and 5' end-labeled 
using T4 polynucleotide kinase and [ T ^ P J A T P (3000 Ci/mmol, Amer-
sham). Aliquots (2 |xl) of in vitro translated proteins were preincu-
bated on ice for 20 min in 18 |0,1 of the binding buffer (10 mM HEPES 
pH 7.4, 50 mM KC1, 1 mM DTT, 5% glycerol) containing 10 ug of 
poly dl-dC and 10 ug of heat treated salmon sperm DNA. Samples 
were incubated for an additional 20 min at room temperature after 
addition of labeled probe(s) (40000 cpm/reaction). The DNA-protein 
complexes were resolved by 5% non-denaturing polyacrylamide gel 
electrophoresis in 0.5-fold concentrated TBE (45 mM Tris, 45 mM 
boric acid, 1 mM EDTA). Gels were dried and autoradiographied at 
-70°C. 
2.6. Statistical methods 
Whenever possible, the results are expressed as means ± S.E.M. The 
significance of differences between groups was determined by the Stu-
dent's Mest. 
3. Results 
3.1. 9-cis-RA enhances L-FABP mRNA levels 
To investigate whether 9-cis-RA was involved in the regu-
lation of L-FABP expression, F A O cells were cultured for 6 h 
with varying concentrations of this RA. Control cultures were 
performed with the vehicle alone (0 .1% v/v DMSO) . As shown 
in Fig. 1A, 9-cis-RA induced L-FABP m R N A in a concen-
tration-dependent manner, the maximal increase occurring at 
10~6 M. Next, the time-course of induction was analysed. 
Cells were treated with 10"6 M 9-cis-RA for 1 to 24 h. Under 
these conditions, increased L-FABP m R N A levels were first 
detected at 1 h, reached a maximum at 6 h, and then de-
creased (Fig. IB). A weaker induction also occurred when 
all trans-RA was used as an inducer (data not shown). 
3.2. Additive effects of 9-cis-RA and LCFA on L-FABP 
expression 
L-FABP gene expression is enhanced by L C F A in F A O 
cells [2]. In order to determine whether R A may potentiate 
this F A action, the effects of 9-cis-RA (10~6 M) and/or oleic 
acid (8 X 10~5 M) on L-FABP expression were studied next. 
Taken separately, compounds triggered an increase in 
L-FABP m R N A level after a 6 h treatment. An additive 
effect was found when the two inducers were applied to-
gether (Fig. 2A). Furthermore, increase in cytosolic L-FABP 
protein contents paralleled that of L-FABP m R N A levels 
(Fig. 2B). 
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Fig. 1. Effect of 9-cz's-RA on L-FABP mRNA in FAO cells. RNAs were extracted from three 60 mm dishes and analyzed as described in Sec-
tion 2. Data were normalized to the amount of 18S rRNA in the samples. (A) Cells were cultured for 6 h with various concentrations of 9-cis-
RA. Control cultures received the vehicle alone DMSO (0.1% v/v). (B) Time course of 9-cis-RA action. Subconfluent cells were maintained in 
serum-free medium throughout the 24 h experiment. 10~6 M 9-cis-RA was added to the medium for 24, 16, 8, 6, 4, 2 or 1 h before the cells 
were harvested. *P<0.05; **P<0.01, n = 3. 
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Fig. 2. Effect of 9-eu-RA and/or oleic acid on L-FABP expression in the FAO cells. Cells were cultured for 6 h in presence of 10~6 M 9-cis-
RA in DMSO (0.1% v/v) and/or 8xl0~5 M oleic acid complexed with 2X10~5 M BSA. Control cultures were performed in presence of 
DMSO and BSA. (A) Bar graph representation derived from 9 independent experiments. Control cultures (black column); cultures plus oleic 
acid (light shaded); cultures plus 9-cis-RA (open); cultures plus oleic acid and 9-CM-RA (dark shaded). **P<0.01; ***/•<0.001. (B) Effect of 
9-cis-RA and/or oleic acid on the cytosolic L-FABP levels in the FAO cells. Ten u\g of cytosolic proteins were analyzed by Western blot as de-
scribed in Section 2. 
3.3. Various PPAR-RXR heterodimers bind the L-FABP 
PPRE 
The additive effect of 9-cw-RA and LCFA on L-FABP 
expression, suggested that a PPAR-RXR heterodimer inter-
acts with the promoter of L-FABP gene, as already found for 
the acyl-CoA oxidase and bifunctional enzyme promoters [7-
9]. Therefore, using the L-FABP PPRE-like sequence as a 
probe, gel shift experiments were performed in order to test 
this working hypothesis and to study the binding properties of 
PPAR-RXR complex to this nucleotide sequence. RXRp" was 
used since it is found in all the tissues where L-FABP is ex-
pressed, e.i. liver, small intestine and kidney [15]. No specific 
retardation was detected when either PPAR (a, (3 or yl) or 
RXRp were used alone (Fig. 3, lanes 2-5). In contrast, specific 
shifts were systematically found when RXR(J was mixed with 
one of the three different PPAR sub-types (Fig. 3, lanes 6-8) 
indicating that RXR and PPAR co-operatively bind to the 
L-FABP PPRE. Differences in the migration of the complexes 
reflect the specific molecular mass of each PPAR checked. 
Similar data were found with the ACO-PPRE taken as con-
trol (data not shown). 
3.4. FAO cells express both PPARa and PPAR$IFAAR 
The expression of different PPAR sub-types in FAO cells, 
was studied next with respect to stimulation with 9-cis-RA 
end LCFA. As shown in Fig. 4 and according to previous 
data performed in rat liver [16], both the mRNA for PPARa 
and PPAR(3/FAAR were expressed in hepatoma FAO cell line 
while PPARyl was undetectable. However treatment of the 
cells with oleic acid and/or 9-cw-RA did not modified the 
PPARa and PPARp/FAAR mRNA levels in contrast to those 
of L-FABP which were increased (Fig. 4). 
4. Discussion 
Retinoids are vitamin A derivatives which exert multiple 
essential functions in development, differentiation, reproduc-
tion and vision. Retinol is metabolized to form retinal and 
retinoic acids, i.e. all-?ra«.y-RA and 9-cis-RA [17], which are 
major vitamin A metabolites involved in the regulation of 
gene expression. This control takes place through the activa-
tion of two distinct classes of nuclear receptors: the RA re-
ceptors (RARa, (3 and y), and retinoid X receptors (RXRa, P 
and y) which bind with high affinity all-trans-KA and 9-cis-
RA, respectively [10,11]. 
Several proteins involved in the lipid metabolism, including 
ACO [7,8], BFE [9], albumin [18] and Apo A-I [19] are di-
rectly modulated by 9-cw-RA. In this report, we provide evi-
dence that L-FABP gene expression is also regulated by this 
vitamin A derivative. The induction is gene-specific (PPARa, 
PPARp/FAAR and p-actin mRNA levels are unaffected), rap-
id (effective 1 h after addition of 9-cis-RA) and triggered by a 
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Fig. 3. Gel shift analysis of the L-FABP PPRE in presence of PPARs and RXRB taken separately or combined. In vitro translated PPARa, 
PPARB/FAAR, PPARy and RXRB were incubated with the labeled L-FABP PPRE as described in Section 2. The ACO PPRE was taken as 
control. Lanes: 1, DNA probe only; 2-5, PPARs or RXRB alone; 6-8, PPAR and RXR combined as indicated at the top of the figure. 
low concentration of inducer (10 - 7 M). We have recently 
reported that the L-FABP gene was up-regulated by LCFA 
in both liver cell lines [2] and small intestine [20]. It is note-
worthy that 9-CM-RA enhances the LCFA induced up-regula-
tion of L-FABP gene expression. 
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Fig. 4. Effect of oleic acid and/or 9-cis-RA on PPAR sub-types ex-
pression in FAO cell line. Northern blot analysis was performed as 
described in Section 2. Cells were cultured for 6 h in presence of 
1(T6 M 9-cw-RA in DMSO (0.1% v/v) and/or 8xl(T5 M oleic acid 
complexed with 2X10-5 M BSA. Control cultures were performed 
in presence of DMSO and BSA alone. 
Recent findings indicate that PPARs bind PPREs as PPAR-
RXR heterodimer and that the complex can be activated by 
both PPAR activator and RXR selective ligands [21]. We 
demonstrate herein that such a heterodimer can also bind 
the L-FABP-PPRE at least in vitro. Since 9-cw-RA and 
LCFA activate RXRs and PPARs, respectively, [10,11,22], it 
is tempting to speculate that, like in the above mentioned 
study, the co-operative up-regulation of L-FABP expression 
triggered by these molecules takes place through such a func-
tional heterodimer that directly binds oleic acid [23] and 9-cis-
RA. The lack of PPARy expression in FAO cells suggest that 
PPARa and/or PPARp/FAAR might be involved in this gene 
regulation. Transfection studies performed in FAO cells and 
the use of PPARa knock-out mice [24] will be used to test this 
hypothesis. 
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